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ABSTRACT
It is estimated that over 150,000 patients will be diagnosed with invasive breast
cancer in 2007. Patients must undergo a mastectomy or a lumpectomy to remove the
cancerous tissue, but only a mastectomy allows breast reconstructive surgery. Due to the
limitations of current reconstruction options, new alternatives are being explored.
Injectable materials have been suggested for breast tissue reconstruction because of their
versatility. Cells cultured on injectable beads form cell carriers that may be mixed with a
hydrogel, resulting in a construct that may be injected through a syringe to restore normal
tissue mass. This solution offers breast cancer patients a new reconstructive option that
employs their own healthy cells.
The long-term objective, beyond the scope of this research, is to develop a novel
injectable composite system, consisting of cellular scaffolds in a hydrogel carrier that
could be injected into a defect site. The primary goal of this research was to develop
viable polymer scaffolds for preadipocyte growth and differentiation and to assess the
cellular response to these scaffolds. Initially, collagen-polylactide beads were developed
and seeded with fibroblasts. The fibroblasts had a high affinity for these beads, but
collagen was not conclusively proven to be present in the microspheres. Subsequently,
polylactide beads with collagen or collagen and linoleic acid coatings were produced.
Preadipocytes were grown on the collagen and collagen/linoleic acid coated beads,
uncoated polylactide beads, or two 2-D controls, and tested for viability, lipid and fatty
acid production, and gene expression.

Few cells were capable of attaching and

proliferating on the uncoated polylactide beads for the entire 18-Day culture period;
ii

however, more cells were able to attach and proliferate on both types of coated
microcarriers. Cell produced more triglyceride on Day 18 of culture on the beads coated
with collagen than the polylactide beads or the polylactide beads coated with collagen
and linoleic acid. Cells grown on both types of coated beads produced more fatty acids
on Day 18 than cells grown on the polylactide beads. The coated beads show potential
for use in the injectable composite system as cellular carriers; however, the polylactide
beads may be better suited for an alternative purpose in this system. Future work is
needed to optimize the linoleic acid concentration as well as to examine other fatty acids
for their effectiveness in inducing differentiation of preadipocytes.
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PREFACE
Current methods of reconstructing breast tissue after a mastectomy or
lumpectomy are limited, so new methods are being researched. Of particular interest is
tissue engineering a minimally invasive device, such as an injectable biomaterial, to
restore the breast tissue without the need for a second surgery. This method will reduce
the pain, scarring, recovery time, and cost that usually occur with reconstructive surgery.
Scaffolds for use in injectable devices are being designed and researched for their ability
to control cellular activity, encourage tissue growth, and provide a temporary filler until
the devices can be replaced by native tissue.
The purpose of this research was to add collagen and linoleic acid to polylactide
microspheres and evaluate the cellular response to such microspheres. Two studies were
conducted.

First, collagen-polylactide beads were manufactured and tested for their

cellular affinity. Second, polylactide beads were coated with collagen or with collagen
and linoleic acid. Cells on both types of coated beads were tested for cell viability,
triglyceride and fatty acid production, and gene expression, and the results were
compared to those derived from cellular polylactide beads as well as 2-D surfaces.

x

INTRODUCTION
Breast cancer is the second most common cancer among women, second only to
nonmelanoma skin cancers. The American Cancer Society estimates that 178,000 new
cases of invasive breast cancer will occur in women in the US during 2007 [1]. Several
potential courses of treatment are considered for these patients. Surgery and therapeutic
options, such as radiation therapy, chemotherapy, and hormone therapy, are considered to
be the standard treatments to remove a tumor. Most patients with breast cancer have
surgery to remove the cancerous tissue; the two most common surgeries are lumpectomy
and mastectomy. A lumpectomy is a breast conserving surgery, which removes the
tumor and a small margin of normal tissue around it, but for which there are no
reconstructive options available. A mastectomy removes the entire breast that contains
cancer, and allows the patient to undergo breast reconstruction.

Breast Tissue Biology
Adipose tissue comprises most of the normal breast and is removed during
mastectomy. This tissue is highly vascularized and has an extensive vascular network.
The volume of an adipocyte is 80 to 95% triglyceride, which is a type of lipid. Mature
adipocytes are terminally differentiated and cannot proliferate, but can increase in size.
Preadipocytes have been investigated for adipose tissue engineering because these cells
are committed to the adipocyte lineage and can increase in number [2]. Preadipocytes
can be advantageous because of their proliferative capacity and ability to differentiate and
form adipose tissue. In vitro, preadipocytes are fibroblast-like in appearance and this

shape is maintained throughout cellular proliferation.

When preadipocytes undergo

differentiation, proliferation is halted and the cells undergo morphological and
biochemical changes [2]. The maturing cells acquire a spherical shape, accumulate
triglyceride, and exhibit mature adipocyte phenotypes.
During the differentiation process, preadipocytes begin to express genes that are
characteristic of adipocytes. Preadipocytes express the gene growth arrest and DNAdamage inducible protein (GADD) 153, also designated C/EBP-homologous protein zeta,
(CHOP-10), which blocks the cell from transitioning from the G1 to the S phase of the
cell cycle [3]. This gene inhibits adipocyte differentiation, and is down regulated as
differentiation begins [3, 4]. Early in the differentiation stages peroxisome proliferator
activator receptor gamma, PPAR-γ, is expressed and levels increase as differentiation
progresses to later stages [2, 4]. PPAR-γ is a nuclear hormone receptor [4, 5, 6] that
promotes and regulates adipogenesis [5, 7, 8]. Adipocyte-specific fatty-acid-binding
protein-2 (aP-2) is a lipid binding protein [9] expressed in mature adipocytes [4, 6, 8].

Traditional Methods of Breast Reconstruction
According to the American Society for Plastic Surgeons, over 50,000 women
opted for reconstructive surgery in 2006 [10]. The goals of reconstruction are to regain
breast contour and chest symmetry, and to help women avoid the feeling of having a
deformity. Reconstruction options include acellular and cellular approaches, which have
their associated complications and disadvantages.
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Acellular options include prostheses, tissue expanders, and implants that are all
available commercially.

Prostheses are worn outside the body and give a natural

appearance when worn under clothing; prostheses lend a non-surgical option. These
devices are mobile and therefore limit the patient’s physical activity; additionally,
prostheses may appear distorted at times. A tissue expander necessitates a surgical
procedure where an empty silicone shell is placed under the muscle wall. The shell is
filled with saline over a period of weeks to months until it is inflated to the proper size.
The shell is then deflated and removed; the void is filled with a permanent implant. Risk
of infection, damage to the expander, discomfort of expansion, a second operation, and a
longer period of reconstruction are all potential negative outcomes following tissue
expansion and reconstruction [11, 12]. Breast implants are silicone shells filled with
either silicone or saline that may be implanted during or after the initial surgery.
Common complications include rupture and subsequent removal of the implant. Scar
tissue may contract and form a hard capsule around the implant, in rare cases masking the
recurrence of breast tumors.
Cellular reconstructive options were initiated with the investigation of autologous
adipose tissue for soft tissue repair. Adipose tissue is found in abundance in many
patients, and is easily harvested [12]. However, when implanted, an adipose tissue graft
volume decreases by 50-70% due to resorption of the tissue [12].

Adipocytes are

anchorage-dependent cells and will not survive without a scaffold on which to grow.
Mature adipocytes cannot grow to replenish the cells lost to resorption because they are
terminally differentiated [12]. A tissue flap is a section of autologous tissue consisting of
3

skin, fat and/or muscle that is transplanted to the breast area [12]. The flap can be shaped
to approximate the size and feel of a normal breast [13]. There are two main types of
flaps; a TRAM flap and a Latissimus flap. The TRAM (transverse rectus abdominus
musculocutaneous) flap is the most commonly excised flap. The abdominal wall skin,
rectus abdominus muscle, and subcutaneous adipose tissue, along with the blood vessels
that supply these tissues are moved to the chest to recreate the breast mound [12]. The
Latissimus flap, including the latissimus dorsi muscle of the back, along with the skin and
fat in the area, is moved to recreate the breast mound. This type of reconstruction
minimizes foreign body response, and the reconstructed site more closely approximates
the feel of a normal breast as opposed to an inert implant [13]. Donor-site morbidity,
abdominal wall weakness or latissimus dorsi muscle atrophy at the donor site, and longer
recovery times are the primary drawbacks of this surgery. These reconstruction options
restore tissue volume, but do not restore tissue function or create a viable tissue mass.

Tissue Engineering as a Method of Breast Reconstruction
Tissue engineering strategies are being investigated for breast tissue
reconstruction. This multidisciplinary field focuses the application of engineering and
life science concepts toward the development of biological substitutes that restore,
maintain, or improve tissue function [14]. Ideally, the engineered tissue integrates with
the host tissue and new native tissue is created. The goal of breast tissue engineering is to
create a volume of viable adipose tissue using the patient’s cells as the building blocks.
Direct autologous fat tissue transplantation is minimally successful because a significant
4

portion of the transplanted tissue resorbs over time leading to visible deformities [15].
Current tissue engineering strategies include scaffold guided tissue regeneration (e.g.,
injectable composite system), tissue based regeneration (e.g., fragmented omentum), and
tissue induced regeneration (e.g., de novo adipogenesis) [15].

Breast Tissue Engineering Scaffolds
Scaffolds employed in adipose tissue engineering need to meet certain criteria.
The scaffold should facilitate the growth of tissue that has the natural feel of the normal
tissue and should conform to the defect site in the original tissue [16, 17]. A viable
scaffold should be biocompatible, facilitate cell adhesion, promote cell growth, and act as
a guide for the three-dimensional growth of cells [16, 17]. The scaffold porosity should
be sufficient for cell adhesion and tissue ingrowth; the scaffold should have a large
surface to volume ratio and should be eliminated completely and replaced by native
tissue over a period of time [16, 17, 18]. The scaffold should degrade at a rate that allows
the timely development of new tissue formation. Absorbable scaffolds are advantageous
because they eliminate the need for a retrieval surgery and their absorption minimizes the
possibility for long-term biocompatibility issues.
Preadipocytes and adipocytes are anchorage-dependent cells; i.e. they require a
biomechanically acceptable substrate in order for normal cell proliferation and
differentiation to occur [19].

Scaffolds can be derived from naturally occurring or

synthetic materials. Naturally occurring materials currently under investigation include
collagen, gelatin, fibrin, alginate, hydroxyapatite, and chitosan [16, 20-22].
5

Natural

polymers are biocompatible, mimic the biochemical structure of the native cellular
environment, and are degradable by enzymatic or hydrolytic mechanisms [22].
Unfortunately, natural materials have many disadvantages, including relatively high
antigenicity, batch to batch variation, and increased risk of transfer of infectious disease.
The most widely used synthetic materials in tissue engineering applications are polymers
[16, 17, 21, 22]. Synthetic polymers are desirable because they have very little variability
from batch to batch, have a wide spectrum of properties, and have tunable degradation
rates. These materials can also be processed into a variety of shapes, such as sponges,
films, and microspheres.

Absorbable and Degradable Polymers
Absorbable polymers are those plastics that are degraded and removed from the
body, while degradable polymers are remodeled and remain in the body. One of the well
known, synthetic absorbable polymers used is polylactide (PL) [16]. The US Food and
Drug Administration has approved PL for human use in absorbable sutures and some
implantable devices. PL has various forms, including poly-L-lactide (PLL), poly-Dlactide (PDL) and poly-D,L-lactide (PDLL). PLL and PDL are semicrystalline polymers
while PDLL is an amorphous polymer. All three forms degrade through hydrolysis to
lactic acid, a normal metabolite that is found in the body and is excreted from the body as
water and carbon dioxide. Select material properties that determine the rate of hydrolysis
are outlined in Table 1.1.

Sterilization method and environmental factors such as

biochemical agents, pH, and temperature will all influence the rate of hydrolysis.
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Polylactides can be made with a variety of properties, allowing them to be used in a large
range of applications. PL can be fabricated into many forms, such as sponges [16],
woven or knit meshes [16], microparticles [23], and films [24]. For PL to be successfully
used as a cellular substrate for adipose tissue engineering, preadipocytes and adipocytes
must be able to adhere to and proliferate and/or differentiate on the scaffold. Conejero
and coworkers seeded fat-derived stem cells onto a PL scaffold and showed that the cells
were able to grow and form a tissue [25]; however, PL is not an ideal scaffold to use as a
cell carrier because it is hydrophobic and releases acidic byproducts as it degrades,
causing the pH of the local environment to decrease. Even though cells do eventually
grow on PL, surface modification of this polymer could allow the cells a more hospitable
surface, leading to immediate cell growth.
Table 1.1 Select material properties determining hydrolytic degradation of absorbable
polymers
Crystallinity
Hydrophobicity/ hydrophilicity
Molecular weight
Porosity
Structure
Synthetic materials alone will likely not create a proper cellular environment.
Natural materials combined with synthetic materials likely provide the ideal environment
for cells, i.e. an environment that is structurally sound and conducive to adhesion and
proliferation. Collagen, a degradable material that is remodeled in vivo by collagenase,
has been widely used in medical applications for many years and plays an important role
in the formation of tissues. Collagen is a crosslinked protein found throughout the human
7

body that is biodegradable, nontoxic, and has weak antigenecity. The properties of
collagen are directly affected by the density of crosslinking and the type of crosslinking
agent employed [26]. Glutaraldehyde is the most commonly used crosslinking agent
because it is inexpensive and provides sustained long-term durability by creating a high
density of covalent crosslinks [26, 27]. Unfortunately, this chemical is thought to cause
long-term cytotoxicity as well as calcification. If no crosslinking agent is used, collagen
is degraded in the body too quickly to be clinically viable.
Tannic acid is a plant polyphenol that has the ability to crosslink proteins and is
rumored to have anti-carcinogenic properties. Tannic acid is capable of crosslinking
proteins because it contains a large number of functional groups. Specifically, hydrogen
bonds form between the phenolic hydroxyl groups on the tannic acid and the carboxyl
groups of the protein [28] thus binding the protein. Hydrogen bonds are lower energy
bonds than covalent bonds; therefore, a tannic acid crosslinked collagen will degrade
relatively fast as compared with a glutaraldehyde crosslinked collagen. Tannic acid is
reported to be an anticarcinogen for certain types of cancer, including mammary cancer,
and is an effective inhibitor of tumors in mice [28]. Tannic acid crosslinking allows the
collagen to degrade within a reasonable time, while also potentially reducing the chances
of tumors recurring.

8

Composite Injectable Systems
An injectable composite system is of particular interest because it is mechanically
similar to soft tissue, conforms to irregular spaces, and may be implanted in a minimally
invasive manner [29]. The composite system is composed of two distinct parts, a rigid
absorbable scaffold for cell attachment and growth, and an absorbable gel to facilitate the
scaffold delivery, as shown in Figure 1. The scaffold should have a diameter smaller
than the gauge of a needle in order to allow injection. This tissue engineering strategy
can be modified so scaffolds of varying properties are embedded within the same
hydrogel to obtain a tunable drug delivery system and tailored absorption profile.
Composite systems, by virtue of their discrete scaffold structure, allow tissue integration
and vascularization within the construct as well as serial implantation, and thus may
allow the reconstruction of larger volumes of tissue than the traditional continuous
scaffolds which are diffusion limited [29].

9

Figure 1.1 The development of injectable composite devices for breast tissue
reconstruction
Maintenance of Adipose Tissue Long-Term
Collagen and PL are effective scaffolds for cell attachment and proliferation, but
differentiation will be key to the long-term maintenance of soft tissue bulk. Satory and
coworkers investigated the effects of conjugated linoleic acid, as a medium additive on
preadipocyte proliferation and lipid filling [30].

Their results showed that certain

concentrations of conjugated linoleic acid in the medium inhibited preadipocyte
proliferation and increased cellular lipid content. Although there are differences between
10

conjugated linoleic acid and linoleic acid, there is not enough detailed research to
determine the effects of each different type of linoleic acid on cellular attachment and
growth. Based upon these results, this study hypothesizes that inclusion of lipid into an
injectable composite system might allow preadipocytes seeded on the scaffolds to
differentiate once injected into the body, while stimulating adipocytes present in the
tissue to retain cellular lipid.

Conjugated linoleic acid has also been shown to be

anticarcinogenic in a rat mammary tumor model [31]
The long-term goal, beyond the scope of this work, is to develop an injectable
biodegradable composite breast tissue reconstruction device with anti-tumor and bulking
capabilities.

This study focuses on designing polymer scaffolds that are viable for

preadipocyte growth and differentiation. Polylactide beads were coated with collagen
and linoleic acid, then seeded with preadipocytes and observed in vitro to assess cell
attachment, growth, and differentiation patterns.
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MATERIALS AND METHODS
To meet the objectives of this research, two primary studies were performed. The
first study determined cell viability on collagen encapsulated polylactide beads. The
second study examined cell viability and differentiation on collagen coated polylactide
beads and collagen and linoleic acid coated polylactide beads. Metabolic activity, lipid
and fatty acid production, cell viability, and gene expression of cells were compared
between the coated polylactide beads, uncoated polylactide beads and 2-D surfaces.

Polylactide scaffolds
Solution Preparation for Emulsion-Solvent Evaporation
Polylactide (PL) pellets were obtained from DOW chemicals (DOW LLC,
Minneapolis, MN). A 10% w/v solution of PL was prepared by dissolving 2 grams of PL
pellets into 20 mL of dichloromethane (Mallinckrodt Inc., Hazelwood, MO) for 48 hours.
A 0.3% solution of PVA was created by adding 3 grams of PVA flakes (Sigma-Aldrich,
St. Louis, MO) into 1000 mL of distilled water, then stirring and heating the solution over
low heat until the PVA was completely dissolved. The solution was then cooled to room
temperature before use. A 2% isopropanol solution was prepared by mixing 20 mL of
isopropanol (VWR, West Chester, PA) with 980 mL of distilled water.

Fabrication Equipment and Procedure
Scaffolds were prepared using an emulsion-solvent evaporation procedure. A
glass tank measuring 24 cm in diameter and 28 cm in height, with a drain located in the
12

bottom that was covered with a brass WireMesh® screen (Paragona®, Stockholm,
Sweden), was elevated on two 2” x 4” risers. Tygon R-3603 tubing (Saint-Gobain
Performance Plastics, Akron, OH) was connected to both the drain at the bottom of the
tank and to the drain in the chemical hood. A paddle stir rod connected to a EUROSTAR
power control-visc overhead stirrer (IKA® Works, Wilmington, NC) was placed over the
tank. A solution of 1000mL of 0.3% PVA and 5000mL of distilled water were mixed
together in the tank to form a 0.05% v/v solution of PVA. The solution was stirred for 5
minutes at 200 rpm.
Twenty mL of 10% PL solution were then poured into a 20cc syringe (BD,
Franklin Lakes, NJ) with an attached 16-gauge needle (BD). The needle was submerged
in the 0.05% PVA solution near the vortex created by the stir rod, and the PL solution
was injected into the PVA solution. The solution of PVA and PL was stirred for 10
minutes at 275 rpm. Once the microspheres were settled to the bottom of the tank, 2/3 of
the PVA solution was drained. Two liters of 2% isopropanol solution were added to the
tank, and then stirred for 5 minutes at 200 rpm to wash the microspheres. The tank was
drained until approximately 1 liter remained. The microspheres and liquid were then
transferred to a 1L glass Pyrex® bottle (Corning, Inc., Corning, NY) using a vacuum
source connected to a 45 mm 3-Port for medium bottles (Bellco Glass, Inc., Vineland,
NJ) by Tygon tubing (Saint-Gobain Performance Plastics). The liquid in the bottle with
the microspheres was removed, and replaced with 200 mL of fresh 2% isopropanol
solution. The bottle was then placed on an orbital shaker (IKA® Works) and shaken at
150 rpm overnight at room temperature. The microspheres were then dried on a Coors®
13

Bichner filter funnel (Fisher Scientific, Fair Lawn, NJ), which had a cellulose grade 1
filter paper (Whatman®, Florham Park, NJ) in place. The filter funnel was inserted into a
500 mL Kimax Erlenmeyer filter flask (Chemglass, Vineland, NJ) and connected to a
compressed air system. The air was circulated over the microspheres for a few hours,
until the microspheres were completely dried, as evidenced by their shiny appearance.
The dry microspheres were transferred to a scintillation vial (Fisher Scientific) and stored
under vacuum.

14
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Figure 1.2 PL scaffold fabrication setup: overhead stirrer (1), glass tank (2), drainage
tubing (3), drain with mesh cover (4) (A); filter setup to dry PL scaffolds: Buchner
funnel (5), and compressed air (6) (B)

Polylactide Microspheres with Entrapped Collagen
Collagen (Invitrogen, Carlsbad, CA) was solubilized by adding 1.5 mL of
collagen to 167 µm of 10x DPBS (Invitrogen), 225 µL fetal bovine serum (FBS)
(Mediumtech, Herndon, VA), 358 µL 1 x Dulbecco’s Modified Eagle’s Medium
(DMEM) (Invitrogen), and 20 µL 1N NaOH, creating 2.27mL of solubilized collagen.
Two ratios of collagen to PL pellets were mixed, 50% collagen to 50% PL, referred to as
solution A, and 75% PL to 25% collagen, referred to as solution B. For solution A, 2.27
15

mL of solubilized collagen was mixed with 5 mL of dichloromethane (Mallinckrodt Inc.)
and 1 gram of PL pellets (Cargill DOW LLC) in a scintillation vial (Fisher Scientific) for
48 hours. For solution B, 2.27 mL of solubilized collagen was mixed with 6.75 mL of
dichloromethane and 1.35 grams of PL pellets in a scintillation vial for 48 hours. PVA
solution and 2% isopropanol solution were prepared as previously described.
Microspheres from these solutions were created using the emulsion-solvent evaporation
technique outlined previously.

Polylactide Microspheres Coated with Collagen
PL microspheres were created using the emulsion-solvent evaporation technique
outlined previously. A mixture of 6 grams of hexanediamine with 100 mL of isopropanol
created a 6% hexanediamine/isopropanol solution. To create a 0.1% tannic acid solution,
0.1 gram of tannic acid was added to 100 mL of distilled water and the solution was
stirred and heated to a simmer.
temperature before use.

The solution was then allowed to cool to room

A collagen/acetic acid solution was created by adding

solubilized collagen to 3% acetic acid (Fisher Scientific) at a ratio of 2:1.
The microspheres were stored under vacuum for 3 Days and then added to a 6%
hexanediamine/isopropanol solution and immersed into a 60°C water bath for 10
minutes. The solution was shaken continuously while in the water bath, to prevent the
beads from adhering to the bottom of the flask. The microspheres were placed on a
cellulose grade 1 filter paper that was placed on a Coors® Bichner filter funnel that was
inserted into a 500 mL Kimax Erlenmeyer filter flask, and washed extensively with
16

deionized water. The microspheres were dried at room temperature under vacuum for
several hours. Once dried, the microspheres were immersed in 0.1% tannic acid solution
at room temperature for 3 hours, and then washed extensively with deionized water. The
microspheres were then immersed into a 2:1 collagen/acetic acid solution for 24 hours at
4°C, with occasional shaking.

After being washed with deionized water, the

microspheres were placed under vacuum until use. These beads will be referred to as
PL+C beads.

Polylactide Microspheres Coated with Collagen and Linoleic Acid
PL microspheres were created using the emulsion-solvent evaporation technique
outlined previously. A mixture of 6 grams of hexanediamine and 100 mL of isopropanol
created a 6% hexanediamine/isopropanol solution. To create a 0.1% tannic acid solution,
0.1 gram of tannic acid was added to 100 mL of distilled water, and the solution was
stirred and heated to a simmer.

The solution was then allowed to cool to room

temperature before use. A collagen/acetic acid/linoleic acid solution was created by
adding solubilized collagen to 3% acetic acid at a ratio of 2:1 to a volume of 3 mL, then 1
mL of linoleic acid bound to bovine serum albumin (Sigma-Aldrich) was added to the
solution and stirred.
The microspheres were stored under vacuum for 3 Days and then added to a 6%
hexanediamine/isopropanol solution and immersed into a 60°C water bath for 10
minutes. The solution was shaken continuously while in the water bath to prevent the
beads from adhering to the bottom of the flask. The microspheres were placed on a
17

cellulose grade 1 filter paper that was placed on a Coors® Bichner filter funnel and
inserted into a 500 mL Kimax Erlenmeyer filter flask, and washed extensively with
deionized water. The microspheres were dried at room temperature under vacuum for
several hours. Once dried, the microspheres were immersed in 0.1% tannic acid solution
at room temperature for 3 hours, and then washed extensively with deionized water. The
microspheres were then immersed into a collagen/acetic acid/linoleic acid solution for 24
hours at 4°C, with occasional shaking. After being washed with deionized water, the
microspheres were placed under vacuum until use. These beads will be referred to as
PL+C+L beads.

Cell Culture
Stir Flask
DMEM (Invitrogen) was supplemented with Fetal Bovine Serum (FBS), Lglutamine, fungizone, and antibiotic-antimycotic. Six Wheaton Celstir spinner double
side arm flasks (Fisher) were used; three flasks for PL beads, and three flasks for PL
beads with entrapped collagen. The walls of the stir flasks were coated with 0.15%
agarose solution (Sigma-Aldrich) to prevent the cells from adhering to the walls of the
flasks. 3T3-M mouse fibroblasts were cultured with supplemented DMEM in a Wheaton
Celstir spinner double side arm flask (Fisher). To each stir flask containing 50 mL of
supplemented DMEM medium, 4x106 cells, and 1.75 mL of either PL beads or PL beads
with entrapped collagen were added. Assays were performed at Day 7 and Day 13.
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2-D Cell Culture
3T3-L1 mouse preadipocytes were cultured on 12-well polystyrene plates
(Corning® Inc.) with 1.5 mL of DMEM-C (Invitrogen) in each well. Initially, 3.125x105
cells were seeded in each well. The cells were cultured at 37°C and 5% CO2, and the
medium was changed every 2 Days.

3-D Cell Culture
3T3-L1 cells were cultured with DMEM-C (Invitrogen) on 12-well ultra low
cluster plates. The wells were coated with 0.15% agarose solution (Sigma-Aldrich) to
prevent the cells from adhering to the wells. To each of 4 wells, 100 µg of microspheres,
3.1x105 cells, and 1.5mL of DMEM-C were added. The microspheres tested in this assay
were the PL beads, PL+C beads, and PL+C+L beads. Assays were performed at Days 4,
10, and 18 using 4 wells per microsphere type per plate. Figure A-1 shows which wells
were designated for each scaffold type and assay.

Material Analysis
Microsphere Characterization
PL microspheres with entrapped collagen were characterized using Fourier
Transform Infrared Spectroscopy (FTIR), and Gomori’s One Step Trichrome. Also, the
microspheres were examined and measured using an inverted microscope.
Fourier Transform Infrared Spectroscopy
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FTIR was performed to identify if collagen was present in the collagen
encapsulated microspheres. The samples were placed onto the Thermo-Spectra-Tech
Foundation Series Diamond ATR (Thermo Fisher Scientific, Inc., Waltham, MA), and
compressed with the compression tower of the Diamond ATR.
FTIR spectra were collected using a Thermo-Nicolet Magna 550 FTIR
spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA) equipped with a
Thermo-Spectra-Tech Foundation Series Diamond ATR (Thermo Fisher Scientific). The
samples were scanned 16 times at a resolution of 4cm-1 from 4000 cm-1 to 525 cm-1 and
ratioed against a background scan collected at the same parameters.

The data was

analyzed using OMNIC ESP version 6.1a software.
Gomori’s One Step Trichrome
Gomori’s One Step Trichrome was used to determine if collagen was present in
the beads. The beads were placed in Bouin’s fixative (Fisher) overnight. The beads were
then washed with distilled water until the water ran clean then placed in Gomori’s One
Step Trichrome stain for 20 minutes. Then beads were transferred directly into 0.5%
aqueous acetic acid for 2 minutes then differentiated in 1% aqueous acetic acid for 1
minute. The beads were rinsed in distilled water and dehydrated in 95% ethyl alcohol
then absolute alcohol. The beads were examined under a steromicroscope and collagen
presence showed as a green coloring on the beads, which was measured qualitatively.
PL coated scaffold properties were characterized using gel permeation
chromatography, (GPC) (Waters, Milford, MA), differential scanning calorimetry (DSC)
(TA Instruments, Inc., New Castle, DE), and gas chromatography (GC) (Agilent
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Technologies, Foster City, CA). The samples tested included PL pellets, PL scaffolds,
PL scaffolds coated with collagen, and PL scaffolds coated with collagen and lipid.
Gel Permeation Chromatography
GPC was conducted to determine the molecular weight and polydispersity of
select PL scaffolds using a Waters HPLC system (Waters), consisting of a Model 610
HPLC pump, a Waters Model 486 UV/Vis detector, and a Waters Model U6K injector.
The samples were dissolved in HPLC grade chloroform (Burdick and Jackson, Miskegon,
MI) at a concentration of 3mg/mL of sample to chloroform.
Differential Scanning Calorimetry
The Thermal properties of the PL were determined using a DSC Thermal Analyst
2000 (TA Instruments, Inc.). The sample weight ranged from 5-10 mg and the samples
were contained in aluminum pans (Perkin Elmer, Wellesley, MA). The samples were
heated at a rate of 10°C/minute from 25°C to 200°C in the first cycle. The samples were
then quenched using liquid nitrogen. Samples were reheated a second time to 200°C at a
rate of 10°C/minute.
Gas Chromatography
GC was used to determine the amount of fatty acid present in the linoleic acid and
collagen coated PL microspheres. A sample of 0.5 mg of microspheres was weighed and
placed in a test tube; volumes of 300 µL of methylene chloride (Fisher Scientific) and 1
mL of 0.5 N sodium methoxide in methanol (VWR) were added to the sample. The tube
was flushed with nitrogen and heated at 90°C for 10 minutes, then cooled to room
temperature. One mL of 14% boron trifluoride in methanol (EMD Chemicals, San
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Diego, CA) was added to the sample and heated at 90°C for 10 minutes. After the
sample was cooled to room temperature, 500 µL of GC grade hexane (Fisher Scientific)
and 500 µL of GC grade hexane containing the internal standard, C23:0 methyl ester (1
mg/mL) (Sigma-Aldrich) was added to the sample. Two mL of deionized water were
added to the sample and the sample was vortexed for 2 minutes, then centrifuged at 1500
x g for 5 minutes. The upper layer of the test tube was transferred to a test tube
containing a small amount of anhydrous sodium sulfate (Fisher Scientific). The liquid
was transferred to a GC vial and was run in the 6850 Series II Gas Chromatograph fitted
with an autosampler (Agilent Technologies). The software used to analyze the data was
Chemstation (Agilent).

Cellular Characterization
Stir Flask LIVE/DEAD
A LIVE/DEAD® Viability/Cytotoxicity Kit (Invitrogen) was used to qualitatively
determine the cellular viability and the cellular attachment to the different microspheres.
Under sterile conditions, the LIVE/DEAD® working solution was prepared according to
the manufacturer’s instructions.

The scaffolds were transferred to a 24-well plate

(Corning® Inc.) into separate wells. Residual medium was aspirated from the scaffolds,
and the scaffolds were rinsed with 1 mL sterile PBS (Sigma-Aldrich). The PBS was
aspirated and 1 mL of the working solution was added to each well. The plate was
incubated for 45 minutes at room temperature and protected from light. Images of the
scaffolds were captured using the Axiovert 135 fluorescent inverted microscope (Zeiss,
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Thornwood, NY)), the SPOT INSIGHT color digital camera (Diagnostic Instruments,
Sterling Heights, MI), and Image Pro Plus 4.5 software (Medium Cybernetics, Bethesda
MD). The wells were evaluated for green fluorescence, indicating viable cells, and red
fluorescence, indicating non-viable cells.
Cellular Imaging
Images of the cells on polystyrene and on each of the microsphere types were
captured on Day 4, Day 10, and Day 18 using the Axiovert 135, Image-Pro 4.1 software,
and a SPOT INSIGHT camera.
Lactic Acid and Glucose Measurements
Lactic acid production and glucose consumption were measured before every
medium change. The lactic acid and glucose present in the medium were measured using
a YSI 2700 SELECT Biochemistry Analyzer (YSI Inc., Yellow Springs, OH).
LIVE/DEAD® Assay
A LIVE/DEAD® Viability/Cytotoxicity Kit (Invitrogen) was used to qualitatively
determine the cellular viability and the cellular attachment to the different microspheres.
Under sterile conditions, the LIVE/DEAD® working solution was prepared according to
the manufacturer’s instructions. The scaffolds were transferred to a new 24-well plate
(Corning® Inc.) into separate wells. Residual medium was aspirated from the scaffolds,
and the scaffolds were rinsed with 1 mL sterile PBS (Sigma-Aldrich). The PBS was
aspirated and 1 mL of the working solution was added to each well. The plate was
incubated for 45 minutes at room temperature and protected from light. Images of the
scaffolds were captured using the Axiovert 135 fluorescent inverted microscope (Zeiss,
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Thornwood, NY)), the SPOT INSIGHT color digital camera (Diagnostic Instruments,
Sterling Heights, MI), and Image Pro Plus 4.5 software (Medium Cybernetics, Bethesda
MD). The wells were evaluated for green fluorescence, indicating viable cells, and red
fluorescence, indicating non-viable cells.
Triglyceride Assay
The total intracellular triglyceride concentration was determined using a
differentiation assay protocol developed by Zen-Bio, Inc (Cultured Human Adipocyte
Differentiation Assay Kit, Zen-Bio, Inc., Research Triangle Park, NC). The medium was
aspirated from each sample; each sample was then rinsed with 1mL of sterile PBS and
the liquid aspirated. The cells were frozen at -80°C for 1 hour and then thawed at 37°C
for 10 minutes. The freeze-thaw cycle was repeated twice. One mL of 1% Triton X-100
(Fisher Scientific) was added to each well to lyse the cells on the scaffolds. The scaffolds
were then incubated at room temperature for 30 minutes. The triton solution with cell
debris was transferred to a microcentrifuge tube and centrifuged for 10 minutes at 3000
rpm. Next, 100µL of each sample was pipetted into wells of a 96-well plate in triplicate.
Glycerol standards with concentrations ranging from 0 to 200µM, shown in Table 1.2,
were prepared by diluting glycerol with an appropriate volume of Nanopure water, then
pipetted in triplicate into the remaining 96-well plate. Subsequently, a volume of 100µL
of InfinityTM triglyceride reagent (ThermoElectron Corporation, Melbourne, Australia)
was added to each well of the plate that contained either a standard or a lysate sample.
The plate was incubated at room temperature for 15 minutes. The absorbances of the
samples in the plate were read at 490 nm using a spectrophotometer (MRX Revelation
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TC, Dynex Technologies, Chantilly, VA). The resulting output included absorbances
with respect to concentrations of the prepared glycerol standard solutions, and resulted in
the generation of a standard curve.

Table 1.2: Glycerol Standard Concentrations
Glycerol
Concentration
(µM)
0
3.125
6.250
12.5
25.0
50.0
100
200

Amount of
Glycerol (µL)

Amount of Water
(µL)

0
0.38
0.76
1.50
3.03
6.1
12.1
24.2

350
349.62
349.24
348.50
346.97
343.90
337.90
325.80

Gas Chromatography
Transmethylation of lipid extracts was performed on each of the samples to
quantify the type and volume of lipid present in the cells. Each sample underwent lipid
extraction before being transmethylated. For lipid extraction, the samples were moved to
a glass tube. A volume of 7.5 mL of 2:1 chloroform (Fisher Scientific) to methanol
(Fisher Scientific) was added, then the tube and contents were vortexed for 3 minutes.
The sample was filtered through a cellulose grade 1 filter paper (Whatman®, Florham
Park, NJ ) into another tube containing 0.58% NaCl2 (Fisher Scientific). The original
tube was then rinsed with 2.5 mL of 2:1 chloroform: methanol, and filtered into the rest
of the sample. The tube was then capped and vortexed for 3 minutes, then centrifuged at
1500 rpm for 5 minutes to separate the phases. The upper layer of methanol and water
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was siphoned off and discarded. The lower layer was evaporated under nitrogen to
dryness. Next, the sample was transmethylated into the same tube in which the sample
was evaporated. To each sample, 300µL of methylene chloride (Fisher Scientific) and
1mL of 0.5 N sodium methoxide in methanol (VWR) was added. The tube was flushed
with nitrogen, capped, and heated for 10 minutes at 90°C. The samples were allowed to
cool to room temperature then 1mL of 14% BFl3 in methanol (EMD, San Diego, CA)
was added to each sample. The samples were heated for 10 minutes at 90°C then cooled
to room temperature.

A volume of 500µL of GC grade hexane (Fisher Scientific)

containing the internal standard, C23:0 methyl ester (1mg/mL) (Sigma-Aldrich) and
500µL of GC grade hexane (Fisher Scientific) was added to each tube. Subsequently,
2mL of deionized water was added to each sample and the samples were vortexed for 2
minutes. The samples were centrifuged for 5 minutes at 1000 rpm. The upper fractions
of the centrifuged tube contents were transferred to a disposable glass vial containing a
small amount of anhydrous sodium sulfate (Fisher Scientific) and maintained for 2
minutes. The liquid was transferred to a GC vial and flushed with nitrogen then capped
and then sampled in the 6850 Series II gas chromatograph fitted with an autosampler
(Agilent) and analyzed using Chemstation software (Agilent).
Reverse Transcriptase Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) analysis was used
to determine if selected genes expressed by preadipocytes or adipocytes were expressed
by the cells in each sample. Samples of ribonucleic acid (RNA) were tested before
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culturing cells and after Day 18 of cell culture on bead scaffolds. Primers for the specific
genes of interest were designed for the RT-PCR reactions.
RNA Isolation
RNA was isolated from the samples to be tested. The medium was aspirated from
the cellular scaffolds and 2-D surfaces, and the samples were rinsed with 1mL of sterile
PBS. The RNA was isolated from the cells using the reagents and instructions from an
RNeasy Mini Kit (QIAGEN, Valencia, CA). The cell membranes of the cell samples
were directly lysed in the well plates by adding 600µL of Buffer RLT (QIAGEN) to each
well. Cells grown on the microspheres were lysed directly on the surface of the beads.
The samples were incubated for 15 minutes at room temperature in the Buffer RLT. The
lysate from each sample was then pipetted onto individual QIAshredder spin columns
(QIAGEN) inserted into 2mL collection tubes. The tubes were centrifuged for 2 minutes
at 13,000 rpm. After centrifugation, 600µL of 70% ethanol were added to the lysate of
each sample and mixed well. A volume of 700µL of the samples was pipetted into an
RNeasy mini column (QIAGEN) placed into a new 2mL collection tube. The tubes were
centrifuged for 15 seconds at 13,000 rpm and the flow-through was discarded. The rest
of the sample solution was pipetted onto the same mini columns, and centrifugation was
repeated for 15 seconds. The flow-through was discarded again and 350µL of Buffer
RW1 was added to each RNeasy column, the mixtures were centrifuged for 15 seconds at
13,000 rpm, and the flow-through was discarded. A solution of 10µL of DNase I stock
solution was added to 70µL of Buffer RDD and mixed gently. The entire solution of
DNase I stock/Buffer RDD (80µL) was pipetted directly onto an RNeasy silica gel
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membrane and incubated at room temperature for 15 minutes. Another 350µL of Buffer
RW1 was added to the RNeasy mini column, the mixture was centrifuged at 13,000 rpm
for 15 seconds and the flow-through was discarded. The RNeasy column was transferred
to a new 2mL collection tube and 500µL of Buffer RPE (QIAGEN) was added onto the
RNeasy column, then centrifuged for 15 seconds at 13,000 rpm, and the flow-through
was discarded. Another 500µL of Buffer RPE was pipetted onto the RNeasy column and
centrifuged for 2 minutes at 13,000 rpm. A volume of 50µL of RNase-free water was
added to the RNeasy columns and the samples were centrifuged for 1 minute at 13,000
rpm. This step was repeated and the sample RNA was collected in a 1.5mL collection
tube. The final volume of each RNA sample was 100µL. All samples were stored at 80°C.
Analysis of RNA Concentration and Purity
The concentration and purity of the isolated RNA samples was analyzed using the
Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.), 2100 Expert Software (Agilent
Technologies, Inc.) RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000
Ladder (Ambion, Inc., Austin, TX), and RNA 6000 Nano LabChip® (Caliper
Technologies Corp., Mountain View, CA). A gel-dye mix was prepared by adding 1µL
of RNA 6000 Nano dye to 65µL of filtered RNA 6000 Nano gel matrix. The gel-mix
was vortexed to mix thoroughly and then centrifuged for 10 minutes at 1400 rpm. After
centrifugation, 9µL of the gel-dye mix was pipetted into the G well of the LapChip®.
The Chip Priming Station (Agilent Technologies, Inc.) pressurized the Chip for 30
seconds according to the manufacturer’s instructions. Another 9µL of the gel-dye mix
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was loaded into the 2 remaining wells on the LabChip® labeled with G. The 5µL of
RNA 6000 Nano Marker was added to each sample well and ladder well. An aliquot of
RNA 6000 ladder was heat denatured at 70°C for 2 minutes then 1µL of the ladder was
pipetted into the ladder well on the LabChip®. The RNA samples were thawed on ice
and 1µL of each RNA sample were added to the samples wells for a total volume of 6µL
per well. The LabChip® was vortexed for 1 minute at 2400 rpm. The chip was inserted
into the Bioanalyzer (Agilent Technologies, Inc.) and analyzed using the Eukaryote Total
RNA Nano program from the 2100 Expert software (Agilent Technologies) to determine
the RNA concentration, RNA integrity number, and the 28s:18s ribosomal ratio. The
RNA samples were returned to -80°C storage.

RNA integrity number (RIN) was

measured on a scale of 0 to 10, where 10 was considered high quality RNA and any
sample that had an RIN below 8 was not used.
RT-PCR Primers
Four genes were selected to test on the sample RNA. Primers were designed for
the following genes for use in the RT-PCR analysis: mouse growth arrest and DNA
damage inducible gene 153 (GADD 153), mouse peroxisome proliferator activator
receptor-gamma (PPAR-γ), mouse adipocyte-specific fatty-acid-binding protein-2 (aP-2),
and mouse beta-actin (β-actin).

GADD 153 was selected to identify cells still as

preadipocytes. PPAR-γ was selected as a mid marker of adipocyte differentiation and aP2 was selected to identify cells in later stages of adipocyte differentiation. β-actin was
used as a housekeeping game. A previous graduate student, Nicole Cavin, designed the
primers and the primer sequences for target genes are listed in Table 1.3. The designed
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primer pairs for each gene were ordered (Integrated DNA Technologies (IDT),
Coralville, Iowa) and the primers were received in lyophilized powder form and each
primer was resuspended in a volume of RNase-free water to provide a 30µM
concentration

stock

primer

solution.

The primers were stored
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at -20°C.
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aP-2

GADD 153

Taget Gene

K02109

ATGTGTGATGCCTTTGTGGGA

TGTTCTCAAATACTTTCCCGT

300

596

396

CGACTCCTCCCCTGACTC

CACATCCCAAAGCCCTCG

X67083

NM_011146 AACCTGCATCTCCACCTTATTATTCTG CTACCGGTGGAGAAACGAGACGAGGAC

305

Amplicon
Size (bp)

AGTACTTCACACTGCAACTGTA

Antisense Primer (3'-5')

CTGACAGACTACCTCATGAAGA

Sense Primer (5'-3')

NM_00393

Accession
Number

Table 1.3: Primer Sequences for Target Genes

RT-PCR
The relative level of gene expression in the RNA samples was evaluated using a
OneStep RT-PCR Kit (QIAGEN). To prepare the RT-PCR reactions, the manufacturer’s
instructions were followed using a Mastercycler Gradient Thermal Cycler (Eppendorf,
Hamburg, Germany). The sample RNA, primers, dNTP Mix, 5x RT-PCR Buffer, RTPCR Enzyme Mix, and RNase-free water were thawed on ice and vortexed to mix. A
gene specific master mix containing 10µL of 5x buffer, 2µL of dNTP mix, 2µL of
enzyme mix, and 1µL each of the forward and reverse primer specific to the selected
gene was prepared for the reactions. The appropriate volume of the master mix was
distributed equally among 0.2 mL PCR reaction tubes (Fisher Scientific). An amount of
20 nanograms of template RNA was used per sample reaction. The RNA samples were
diluted with RNase-free water to obtain a measurable volume of RNA that could be
pipetted into each reaction tube. The final volume of each reaction sample was 50µL,
reached by the addition of RNase-free water to make up the difference. The thermal
cycler conditions were set to include the following steps: reverse transcription of the
mRNA sample, initial activation of PCR, denaturation of the DNA double strand,
annealing of the primer to the DNA strands, and extension samples.
The optimal number of cycles for denaturation, annealing, and extension was
determined for each primer pair. The PCR reactions were prepared as described above.
The template RNA was diluted with RNase-free water to obtain a measurable volume of
RNA.

No template control (NTC) samples without the template RNA were also
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prepared. For the NTC samples, the total volume of 50µL was achieved by the addition
of more RNase-free water.
The optimal annealing temperature for each of the primer pairs was also
determined, and PCR reactions were prepared as described above. The template RNA
was diluted 1:10 with RNase-free water to obtain a volume of at least 1 µL. Minus-RT
control samples were prepared without the RT-PCR Enzyme Mix, and the volume was
compensated with additional RNase-free water.

The annealing temperature in the

thermal cycler program was set at 48°C with a gradient of 5°C, in order to encompass the
different annealing temperatures, for which each of the primers was evaluated.
Table 1.4 Annealing Temperatures and Cycle Numbers
RT-PCR Step
Annealing

Targeted
Genes
B-actin

Time
(Minutes)
1

Temperature
(°C)
52.5

Number of
Cycles

GADD 153

1

55.3

35

aP-2

1

53.5

35

35

Gel Electrophoresis
The RT-PCR reactions in the thermal cycler produced cDNA strands of each
sample that were evaluated using gel electrophoresis to assess the expressed gene
products.

The following methods for gel electrophoresis were used to evaluate the

products of the primer optimization samples as well as the RT-PCR products of the cell
sample reactions. A 1X Tris Acetate EDTA (TAE) buffer was prepared by adding 900
mL of distilled water to 100 mL of UltraPureTM 10X TAE Buffer (Invitrogen). A 2%
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agarose gel was prepared by dissolving 2g of agarose (Invitrogen) in 100mL of 1X Tris
Acetate EDTA (TAE) buffer. The agarose was heated for 2 minutes to completely
dissolve the powder. Ethidium bromide (Invitrogen), at a concentration of 0.5µg/mL,
was added to the agarose to stain the gel. The agarose was poured and allowed to solidify
for 1 hour, creating gels with 20 wells (Horizontal Electrophoresis Systems, Fisher). The
electrophoresis tray was filled with 1X TAE until the gel was completely covered. A 6X
solution of bromophenol blue loading dye was prepared by adding 0.025g of
Bromophenol Blue (BioRad Laboratories, Hercules, CA) to 10mL distilled water, and
3mL of glycerol (Fisher Scientific). The loading dye was added to each DNA sample to
achieve a final concentration of 1X. A volume of 12µL of each sample was loaded into
an individual lane of the agarose gel. A 100 base pair DNA ladder (Promega, Madison,
WI) was loaded into the first lane of the gel. Electrophoresis was conducted for 2 hours
at 5 kVolts per centimeter (Model FB300, Fisher Scientific). The gel was then viewed
using a UV-Spectroline® BI-O-VisionTM UV/White Light Transilluminator (Spectronics
Corporation, Westbury, New York) and a GEL LOGIC 100 Imaging System (Kodak,
Rochester, NY). A software package, 1D Image Analysis Software (Kodak) was used to
analyze the gels qualitatively and to measure the relative levels of gene expression based
on the intensity of the resulting bands at the expected amplicon size.
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RESULTS
Material Characterization
Stereomicroscopy
The collagen entrapped beads had an average diameter of 83µm ± 16.7µm. The
beads were shiny and appeared to have bubbles beneath the surface of the beads. Most of
the beads were spherical but some were oblong.

Beads fixed with gomori’s were

examined using a stereoscope. Most of the beads had a yellow tint because of Bouin’s
fixative; a few beads looked green.
Polylactide beads had an average diameter of 1.02mm ± 0.21mm. They were
shiny with a smooth white surface. Most of the beads were spherical but some were
oblong. The collagen coated polylactide beads had an average diameter of 1.10mm ±
0.35mm. They appeared white and opaque and were spherical in shape. The collagen
and linoleic acid coated polylactide beads had an average diameter of 1.11mm ± 0.27mm.
The beads appeared white and opaque and were spherical in shape.
Fourier Transform Infrared Spectroscopy (FTIR)
The presence of collagen may be determined by FTIR analysis, where one would
expect peaks at three amide bonding wavenumbers, 1647, 1547, and 1240. The graph
shows a subtraction of the results from the PL beads from those of the PL beads with
entrapped collagen. Some small peaks appear at the bonding regions for collagen, but the
amplitude is not large enough to conclusively determine that collagen is present in the
beads.
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A

B
C

Figure 1.3 FTIR graph. Wavenumber 1647 (A), 1547 (B), and 1240 (C)

Gel Permeation Chromatography (GPC)
The weight average molecular weight (Mw) and the polydispersity of the original
PL pellet and PL scaffolds were determined using GPC. The as received PL had a Mw of
193 kDaltons and a polydispersity index of 2.98 whereas the PL beads had a Mw of 205
kDaltons with a polydispersity index of 1.86. In the graphs, the first large peak is the
molecular weight of the polymer. The following large peaks are solvent peaks. The as
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received PL had a significantly higher (p<0.05) Mw than the Mw of the PL scaffold
(Figure 1.4 A and B). The polydispersity of as received PL and PL scaffolds were not
different (p<0.05).
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A
Figure 1.4 Sample GPC plots (A) as received PL pellet, (B) PL scaffold
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B
Figure 1.4 Sample GPC plots (A) as received PL pellet, (B) PL scaffold

39

Differential Scanning Calorimetry
Analysis of the as received PL pellet showed no glass transition temperature, or
crystallization peak during the first or second heat but a small peak for melting
temperature was present on the first heat. Analysis of the PL fabricated bead also showed
no glass transition temperature, or crystallization peak during the first or second heat but
a small peak for melting temperature was present on the first peak. The melting peaks for
both samples were present at approximately 150°C.
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Figure 1.5 Sample DSC plots. (A) PL original pellet initial heating cycle, (B) PL
scaffold first heat
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Gas Chromatography
An average profile of the amount and type of fatty acid present in the beads was
obtained. An internal standard was added to every sample; the corresponding peak
appeared around 47 minutes. The calculations that were performed to determine the
amount of total fatty acid present without the internal standard is shown below.

Total " ISTD
=Total fatty acid present
ISTD
Total= total amount of fatty acid in entire sample

!

ISTD= internal standard added
Analysis of the PL beads revealed two fatty acids that were present in large
amounts, capric acid and palmitic acid. Analysis of the PL+C beads also revealed large
amounts of capric and palmitic acid. Analysis of the PL+C+L beads did not reveal a
discernible peak for capric acid, but did reveal a peak for palmitic acid. The latter
analysis revealed a peak for linoleic acid, as well as many more peaks than those found
on analysis of the other two bead systems. The linoleic acid was also tested to determine
its purity. It consisted of 90% linoleic acid and 10% other types of fatty acids.
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A

B

C
Figure 1.6 Graphs of GC results. (A) PL beads, (B) PL+C beads and (C) PL+C+L
beads

Cellular Characterization
Stir Flask LIVE/DEAD
No cells attached to the PL beads by Day 7; rather the cells aggregated and
floated in the medium. Cells aggregated on the some of the collagen enhanced beads,
causing select beads to aggregate; however, not all of the beads supported cell
attachment. By Day 13, some cells had attached to a few PL beads, mainly on the
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smaller beads. Most of the PL beads with entrapped collagen were covered with cells
and aggregated in large numbers.

A

B

C

D

Figure 1.7 Live/Dead photographs of cells seeded on PL beads (A), PL beads with
entrapped collagen (B) at Day 7, and PL beads (C) and PL beads with entrapped
collagen at Day 14. All images were taken at a 50X total magnification

Cellular Imaging
Figure 3 shows the cells seeded on tissue culture treated polystyrene well plates in
DMEM, i.e., the “negative controls”, and shows cells seeded on tissue culture treated
polystyrene well plates in DMEM supplemented with 20 µL linoleic acid, i.e., the
“positive” controls.

At Day 4, both cell populations were visually similar to
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preadipocytes. By Day 18, cells in the negative control group appeared to produce small
lipid droplets, but retained their fibroblast-like appearance. Cells cultured with 20 µL
linoleic acid appeared to produce many lipid droplets, some of which coalesced into a
single large lipid droplet in the cell. Many more cells in the positive control culture
produced lipid by Day 18 than cells in the control culture.
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Figure 1.8 Cells seeded on polystyrene. Negative control Day 4 (A) Positive control Day
4 (B), Negative control Day 10 (C), Positive Control Day 10 (D), Negative control Day
18 (E), Positive control Day 18 (F)
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Lactic Acid/ Glucose Measurements
The anaerobic metabolic activity of the cells was analyzed by testing the amount
of lactic acid produced and glucose consumed by the cells at every medium change.
Increases in lactic acid production indicate the cells are metabolically active. All of the
samples except for PL and PL+C+L had significantly increased (p<0.05) the amount of
lactic acid on Day 18 compared to Day 4. Between Day 10 and Day 18, all groups
showed a significant increase (p<0.05) in the amount of lactic acid produced. The
negative and positive control groups produced significantly higher (p<0.05) amounts of
lactic acid by Day 18 than the other (experimental) samples.

Figure 1.9 Lactic acid concentrations for the different scaffolds over 18 Days in culture.
Standard deviation of 4 samples
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The PL+C+L cellular group was the only group that did not have a significant
decrease (p<0.05) in the amount of glucose between Day 4 and Day 18, although
differences existed for this group between Day 2 and 18. Between Day 10 and Day 18,
all groups significantly decreased (p<0.05) in glucose concentration. On Day 18, the
negative control group and the positive control group had significantly lower (p<0.05)
glucose concentrations than any of the other groups.

Figure 1.10 Glucose consumption for different scaffolds during 18 Days in culture.
Standard Deviation of 4 samples
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LIVE/DEAD Assay
Live/dead pictures were taken at Days 4, 10, and 18 for each of the 3-D scaffolds.
Pictures of cell growth on Day 4 are shown in Figure 1.6. No cells visibly grew on the
PL beads by Day 4, but cells grew in clusters in the medium. There were no dead beads
present. Cells began attaching to the PL+C beads by this time point, and some beads
were almost completely covered by live cells. Dead cells were co-localized with live
cells on some beads, while others were completely acellular. The cells began to grow on
the PL+C+L, almost completely covering the beads.

Figure 1.11 Live/Dead results showing cells seeded on PL beads (A), PL+C beads (B),
and PL+C+L beads (C). All images were taken on Day 4 at 25X total magnification
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Cells began growing on some of the PL beads (Figure 1.7) by Day 10. Many of
the PL scaffolds did not support cell attachment.

The beads that did support cell

attachment also had attached dead cells. Some PL+C beads were completely covered by
live cells, and almost all of the beads had some live cell attachment. A small number of
dead cells were visible on the beads. Some PL+C+L beads were completely covered by
live cells, and most of these beads had live cells attached. A small numbers of dead cells
were visible on the PL+C+L beads.

Figure 1.12 Live/Dead pictures of cells seeded on PL beads (A), PL+C beads (B), and
PL+C+L beads (C). All images were taken on Day 10 at 25X total magnification
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The PL scaffolds had a minimal number of beads covered with cells at Day 18
(Figure 1.8). Some of beads that had attached cells appeared to be almost completely
covered with cells. Some of the attached cells bridged two or more beads. Cells were
present on the PL+C beads and most of the beads appeared to be completely covered by
the cells. There were more cells present on the beads than on Day 10. A minimal
number of dead cells were visible on all of the beads. The PL+C+L beads also had cells
present on most of the beads, where most beads appeared to be completely covered by
cells. A minimal number of dead cells were visible on all of the beads.

Figure 1.13 Live/Dead photographs of cells seeded on PL beads (A), PL+C beads (B),
and PL+C+L beads (C). All images taken on Day 18 at 25X total magnification
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Triglyceride Determination Assay
The total amount of triglyceride produced by the cells per scaffold type was
determined at each time point. The triglyceride concentrations measured for each type of
sample at each time point are summarized in Table 1.5. The triglyceride content for the
cells seeded on the negative control, positive control, and the PL beads did not
significantly increase (p<0.05) over the course of 18 Days. Cells seeded onto PL+C
beads and PL+C+L beads, had a significant increase (p<0.05) in triglyceride from Day 4
to Day 18.

Table 1.5: Triglyceride Measured in Cell Samples
Day
4
4
4
4
4
10
10
10
10
10
18
18
18
18
18

Scaffold
Negative
Control
Positive
Control
PL
PL+C
PL+C+L
Negative
Control
Positive
Control
PL
PL+C
PL+C+L
Negative
Control
Positive
Control
PL
PL+C
PL+C+L

Average Triglyceride Conc. (µM)
42.3 ± 5.56
41.8 ± 14.69
48.63 ± 6.88
30.4 ± 5.26
33.63 ± 4.36
46.8 ± 3.53
42.2 ± 3.21
53.48 ± 5.15
52.04 ± 3.00
51.7 ± 6.54
49.7 ± 4.96
51.09 ± 2.54
39.66 ± 12.92
61.29 ± 1.47
49.4 ± 10.14
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As shown in the graph, cells grown on PL beads had a significantly higher
(p<0.05) concentration of triglyceride than cells grown on PL+C beads and PL+C+L
beads by Day 4.

Cells cultured with 20 µL linoleic acid (positive controls) had a

significantly lower (p<0.05) concentration of triglyceride than the cells grown on each of
the bead scaffolds by Day 10. At Day 18, cells grown on PL+C beads had a significantly
higher (p<0.05) concentration than cells grown on PL beads and cells grown on PL+C+L
beads, but had a non-significantly different concentration than the cells in the two 2-D
control groups.

Figure 1.14 Concentrations of triglyceride produced by cells at each time point for each
scaffold
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Total Fatty Acid Content
The amount and type of fatty acid produced by the cells on each substrate was
determined for each time point and shown in Figure 1.15. The positive control had the
largest amount of fatty acid on Day 18 than any other group. These cells also had a
significant increase (p<0.05) in the total amount of fatty acid between Day 10 and Day
18. Cells grown on PL beads had significantly decreased (p<0.05) in the total amount of
fatty acid produced from Day 10 to Day 18. Cells grown on PL+C and PL+C+L
scaffolds did not significantly (p<0.05) increase or decrease in the total amount fatty acid
from Day 4 to Day 18. On Day 4, there were no significant differences between any of
the groups. On Day 10, cells grown on the negative control scaffold had a significantly
lower (p<0.05) amount of fatty acid than cells grown on PL beads and on PL+C beads.
Also, the cells grown with 20 µL linoleic acid had a significantly lower (p<0.05) amount
of total fatty acid than cells grown on PL+C beads. On Day 18, fatty acid content of cells
grown on PL+C beads and PL+C+L beads were not significantly different (p<0.05) from
each other, but both were significantly different (p<0.05) from total content of each of the
other groups.
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Figure 1.15 Total amount of fatty acid content in every sample at each time point
The fraction of linoleic acid that contributes to the total fatty acid content is
displayed in Figure 1.16. The calculations to determine the percentage of linoleic acid in
each sample are shown below.
( Area ISTD)
*100 =Percentage of linoleic acid present
(Total " ISTD)
ISTD

Area= area of peak measured
!

ISTD= internal standard
Total= total amount of fatty acid in entire sample
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No measurable amounts of linoleic acid were detected in the cells grown on the
PL+C+L scaffold at any time point. One sample, with cells grown on PL scaffolds, and
one sample, with cell population grown on PL+C scaffolds, had linoleic acid present on
Day 10, but no other cell populations grown on these two scaffolds had linoleic acid
present at any time point. Cells grown on the negative control scaffold had incorporated
levels of linoleic acid on Days 4 and Day 18. There was a significant increase (p<0.05)
in the amount of linoleic acid in the cell population grown on the control scaffold
between Day 4 and Day 18. Cells cultured with 20 µL of linoleic acid (positive control)
had a significantly larger (p<0.05) amount of intracellular linoleic acid than any other
group at any time point. The amount also significantly increased (p<0.05) between Day 4
and Day 10.
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Figure 1.16 Percentage of linoleic acid in every sample at each time point

RT-PCR
RNA Purity and Concentration
The samples from the 2-D scaffolds, and from the PL+C+L scaffolds had RINs of
8 or better, but the samples from the PL and PL+C scaffolds did not have high enough
RINs and were not included in further analysis. The concentration of RNA, the rRNA
ratio, and the RIN for each sample for Day 18 can be found in Table 1.6. There is no
evidence of DNA contamination.
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Table 1.6 Bioanalyzer Results for Day 18
Concentrati
Ratio
RNA Integrity
Scaffold on (ng/uL) 18s:21s
Number
Day 0
3
0
N/A
Control
113
2.4
10
Control
102
2.7
N/A
Control
79
23.5
10
Control
100
2.9
N/A
20uL
72
2.6
10
20uL
30
2.6
10
20uL
110
2.5
10
20uL
73
2.5
10
PL+C+L
13
3.1
9.9
PL+C+L
12
2.8
9.3
PL+C+L
10
3.0
9.5
PL+C+L
6
0
N/A

Gel Electrophoresis
All of the cell populations from the negative control, the positive control, and
from the PL+C+L scaffolds expressed β-actin. The samples that did not have an RIN
number also expressed β-actin. Three cell populations seeded on the negative control
expressed GADD 153, while only one cell population expressed aP-2.

One cell

population seeded on the PL+C+L beads expressed GADD 153 while two cell
populations expressed aP-2; the groups expressing aP-2 were mutually exclusive from the
groups that expressed GADD 153. The cell population that expressed GADD 153 was
also the same group that did not have an RIN and had a ratio of 18s:21s of zero. All four
cell populations cultured in 20 µL expressed GADD 153, while only two populations
expressed aP-2. PPAR-γ was not detected in any samples. Also, Day 0 samples (before
seeding the cells onto scaffolds) were tested and the resulting gel showed a weak band for
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β-actin, with no expression of GADD 153 or aP-2. The latter cannot be trusted because
of the 0 ratio of 18s:21s and the lack of an RIN.
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A

B

C

Figure 1.17 Gel electrophoresis results for cells seeded on negative controls, PL+C+L
scaffolds, and positive controls for (A) Beta-Actin, (B) GADD 153, and (C) aP-2
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DISCUSSION
The main objective of this research was to design 3-D polymer scaffolds that are
viable for preadipocyte growth and differentiation and to assess the behavior and gene
expression of cells grown on these scaffolds. Polylactide, a synthetic polymer, was used
to fabricate control scaffolds to compare with polylactide scaffolds coated with collagen
or collagen and linoleic acid. Each of these scaffolds was tested to determine its potential
in an injectable composite for breast tissue engineering.
Polylactide beads were fashioned and used as the base for each type of scaffold
created in this study.

As an unmodified microsphere, polylactide has a smooth,

hydrophobic surface. Cells have a low affinity to polylactide; to increase its cellular
affinity, it is desirable to modify the polylactide to a more desirable configuration by
altering the macroscopic structure or the surface characteristics.

In order for 3-D

polylactide scaffolds to have the potential to induce new adipose tissue formation, it will
be necessary for these microspheres to support preadipocyte cell attachment.
Collagen was chosen as the surface coating material for polylactide because of its
biodegradable and nontoxic properties. It is hydrophilic and, because it is a natural
material, has cell recognition sites that facilitate cellular attachment. Linoleic acid was
coated onto a set of beads with collagen to encourage preadipocyte differentiation and,
eventually, adipocyte lipid filling.
Initially, collagen was added to a solution of polylactide before being made into
beads. Beads from this mixture were almost 13 times smaller than PL beads. Fibroblasts
were shown to have a high affinity to these collagen encapsulated PL beads, shown by
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the larger number of cells attached to these scaffolds than the PL microspheres and the
continual cellular proliferation on the collagen encapsulated beads. Collagen inside the
beads could have increased cell affinity once released from the bead, due to the
collagen’s compatible chemistry, although collagen was not conclusively proven to be
present by Gomori’s One Step Trichrome or FTIR. The dramatic difference in size
caused by the addition of collagen is also a likely reason cells had a greater affinity for
these beads [32, 33]. These beads also appear to contain bubbles (not shown), which may
have affected the surface of the beads and therefore affected cell attachment and growth.
Although one or more of these reasons could have affected cell affinity for these beads,
the increased cellular affinity is most likely due to the smaller size of these beads.
Since collagen was not proven present in the previous beads, collagen was added
to the polylactide using a different method. Hong and colleagues created a way to graft
collagen to the surface of PL beads, thus ensuring collagen was present on the surface of
the beads [34]. For one set of beads, linoleic acid was added to the solubilized collagen
before coating. Both types of scaffolds were tested with preadipocytes.
In the final cell test, the scaffolds tested were PL beads, PL beads coated with
collagen and PL beads coated with collagen and lipid. The coating of the scaffold
influenced cellular attachment and behavior as showed from the LIVE/DEAD® assay,
triglyceride assay, gas chromatography, RT-PCR, and lactic acid/glucose measurements.
The preadipocytes cultured on both types of coated PL scaffolds attached to the scaffolds
at an early time point, proliferated, and maintained or increased in total fatty acid content
and triglyceride concentration throughout the entire study. The preadipocytes cultured on
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the uncoated PL scaffolds had a later time point for attachment, and either maintained or
decreased in total fatty acid content and triglyceride concentration; only a few scaffolds
supported cell attachment.
The metabolic activity of the cells was determined by the lactic acid/glucose
assay. Glucose, supplied in the medium, is the “food” for the cells and decreases in
glucose concentration in the medium indicate an increase in overall metabolic activity.
Medium from all of the scaffolds continually decreased in glucose concentration from the
second Day of the study to the last Day of the study. Lactic acid is waste produced by
active cells and increases in lactic acid concentration in the medium indicate overall
metabolic activity. In all scaffolds except PL beads and PL+C+L, beads lactic acid
concentration increased between Day 4 and Day 18. All scaffolds increased in lactic acid
production between Day 10 and Day 18.
These results suggest that the cells are proliferating on the all of the scaffolds.
Lactic acid results for cells cultured on PL and PL+C+L beads show there was possibly a
delay in significant cell growth until Day 10, although glucose consumption had
increased since the beginning of the culture.

For the PL scaffolds, this delay in

significant lactic acid production is due to the fact that cells have a low affinity for the
surface of the beads so have a harder time attaching and then dividing.
Interestingly, all scaffolds significantly decreased in lactic acid concentration
from Day 4 to Day 6 and all scaffolds except for PL and PL+C+L increased significantly
from Day 2 to Day 4. The increase on Day 4 is because the cells that attached on Day 2
are dividing. There was no increase for cells cultured on PL beads; far fewer cells
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attached to these relatively hydrophobic scaffolds and these cells probably did not divide
immediately.

The introduction of the linoleic acid may have disturbed the natural

progression of cellular attachment and division. Cells could attach to the beads, but once
there, many of the cells may have focused on remodeling the linoleic acid before
dividing, which would explain why there is a non-significant increase.
LIVE/DEAD images for the 3-D scaffolds show quantitatively that cells grown on
all of the scaffolds increased in number during the culture period, but at different rates.
Cells grown on PL beads took the longest to start growing on the beads and the fewest
cells visible. It was not until Day 10 that any cells were seen growing on the PL beads
and at Day 18, only a few beads were partially covered with cells. For cells grown on
both PL+C and PL+C+L beads, cells had already attached to the beads by Day 4,
qualitatively increasing in cell number at each time point. By Day 18, most of the beads
of both material types were almost completely covered. For all bead groups, beads
without live cell attachment also did not have dead cell attachment, indicating that cells
never attached to these beads.
It was expected that a larger number of cells would attach to the coated beads due
to the presence of collagen. Research by von Heimburg and coworkers showed the
affinity of preadipocytes to collagen scaffolds and that the cells also differentiated into
mature adipocytes on the collagen scaffolds [35]. It was easier for the cells to attach to
the collagen than the PL surface because the collagen is a natural, hydrophilic,
nonantigenic material and it is recognizable to the cells. Both types of coated beads
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facilitated improved cell attachment and cell proliferation rate as compared with the plain
PL beads.
The triglyceride and total fatty acid assays measured production of triglyceride
and fatty acid, both of which are produced by maturing preadipocytes and adipocytes.
Triglycerides are composed of a glycerol and three fatty acids. The triglyceride assay
measures glycerol concentration while gas chromatography breaks down all complex
fatty acids to measure each fatty acid individually. The results from the triglyceride
assay should correlate with the results from the gas chromatography assay. Increases in
either could be due to an increase in cell number or due to an increase in cell
productivity. Some of the triglyceride groups had a large standard deviation due to
inconsistent cell growth between the different samples in each group.
Cells grown on the negative control 2-D surfaces did not display an increase in
triglyceride or total fatty acid content, but did display a significant increase in linoleic
acid from Day 4 to Day 18. The cells cannot produce linoleic acid, so any linoleic acid in
the cells must be extracted from the medium or scaffolds and then incorporated into the
cells. This increase indicates that linoleic acid was present in the medium and that the
cells were incorporating fatty acids. Images taken of these cells showed that most cells
still maintained fibroblast-like morphologies on Day 18, but that some had developed
rounded morphologies. Fischbach and coworkers showed that preadipocytes did not
differentiate in culture without differentiation inducers [36].

Cells cultured on the

positive control scaffolds increased in total fatty acid content between Days 10 and 18
and specifically increased in linoleic acid between Days 4 and 10. Images on Day 10
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showed some cells with rounded morphology and, by Day 18, some cells with lipid
droplets present.

The addition of linoleic acid to the medium, with no other

differentiation inducers, facilitated a quicker transition from a fibroblast-like state to a
round, lipid filled state.
The cells cultured on the 3-D scaffolds developed more slowly than the cells
cultured on the 2-D scaffolds. Cells cultured on PL beads had constant triglyceride
production and a decrease in total fatty acid content over the entire culture period. Since
the lactic acid/glucose measurements indicate that cell numbers increased between Days
10 and 18, the cells created less triglycerides and fatty acids as time progressed. Samples
from both PL+C and PL+C+L scaffolds increased in triglyceride but not in total fatty
acid. This occurrence is most likely due to an increase in the number of cells as time
progressed, as indicated by the lactic acid/glucose measurements. The results from the
triglyceride assay and total fatty acid assay should show similar trends for each of the
samples, but there were significant differences between the results derived from the two
assays.

This difference is most likely due to the fact that the procedure for gas

chromatography has not been optimized for cells grown on polymer beads.
Only two individual cultures, of all the 3-D scaffolds samples, had linoleic acid
present and it was only present on Day 10. These samples were not extracted from the
cells cultured on the PL+C+L beads, so the linoleic acid was not from the initial coating
of the beads. The linoleic acid was not present in other cultures from the same group and
sample day, and was not present in previous or later days. This result therefore is most
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likely an artifact due to from insufficient rinsing of these two samples on that particular
day, rather than as a result of cells incorporating the linoleic acid.
RT-PCR was used to analyze gene expression of specific preadipocyte and mature
adipocyte genes. The expression of these genes helps to determine the extent of cell
differentiation. Gene expression was analyzed for cells cultured on the control 2-D
scaffolds, cells cultured on 2-D scaffolds with 20 µL of linoleic acid, and cells cultured
on PL+C+L scaffolds. An RIN of less than 8 is not viable for further testing. Cells
cultured on PL beads and PL+C beads were extremely low in number and therefore did
not have enough viable RNA to test for gene expression.
The primers for β-actin, GADD 153, PPAR-γ, and aP-2 were designed by Nichole
Cavin, though the optimal primer conditions were different than previously recorded
[37]. PPAR-γ was not detected in any sample. This is most likely due to incorrectly
designed primers or conditions for the assay were not properly optimized for this primer.
The cells grown on the control 2-D scaffold expressed GADD 153 in three of the four
samples, and one of those samples also strongly expressed aP-2. All four of the samples
of cells supplemented with 20 µL linoleic acid expressed GADD 153; two of those
samples expressed it very strongly. Two of the cultures expressed aP-2 weakly. These
results indicate that both 2-D scaffolds had cell populations consisting of preadipocytes
and mature adipocytes. Only one sample of cells grown on PL+C+L beads expressed
GADD 153, while two different samples grown on these beads expressed aP-2 weakly.
GADD 153 is a growth arrest gene that is expressed during a cell’s exit from the
growth cycle and entry into differentiation. It has been reported that GADD 153 is
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expressed during growth arrest in preadipocytes, then down regulated as the
preadipocytes enter the differentiation cycle [38]. However, Darlington and coworkers
report that GADD 153 is expressed at low levels in confluent preadipocytes and is
suppressed throughout clonal expansion before adipogenesis [39].

GADD 153 is

elevated on Day 4 of differentiation and remains elevated throughout differentiation [39].
Literature reports do agree that GADD 153 is not expressed until cells become confluent.
The expression of GADD 153 in the results published here indicate that the cells from all
three scaffold types tested are, at the very least, entering the differentiation stage by
undergoing growth arrest, which is the first stage of differentiation.
Two cells populations grown on the control 2-D scaffold and two cell populations
grown on the 2-D scaffolds with 20uL linoleic acid supplement expressed both GADD
153 and aP-2. Since aP-2 is only expressed in mature adipocytes, these results indicate
that the cell populations of these scaffolds are a heterogeneous mix of preadipocytes and
mature adipocytes. Two populations of cells grown on PL+C+L beads expressed aP-2
but did not express GADD 153, although one other population of cells grown on
PL+C+L did express GADD 153.

This result indicates that cells grown on these

scaffolds are also a heterogeneous mix of preadipocytes and mature adipocytes.
Since there are conflicting reports regarding the timing of GADD 153 expression
during preadipocyte differentiation, and without knowing the expression profile for
PPAR-γ, it is difficult to know why some cell populations are not expressing GADD 153
at all. The samples that contain no GADD 153 could either be preadipocytes before
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growth arrest, preadipocytes undergoing clonal expansion, or preadipocytes undergoing
differentiation, depending on which previous research is to be believed.
Even though cells could attach to all of the microspheres, regardless of the surface
chemistry, the cell numbers are different when comparing those cultivated on PL surfaces
and those cultivated on collagen PL surfaces. The addition of collagen to the surface of
the beads significantly increased the cell attachment rate and possible growth rate.
Relatively more cells were observed on the beads with collagen and with collagen and
linoleic acid surfaces than on the PL beads. The collagen presented a compatible surface
for the cells to recognize and bind to.
The effect of adding linoleic acid to the surface of the beads was not clearly
determined.

McNeel and coworkers found that the effect of linoleic acid on

preadipocytes was the same no matter the type of isomer [40]. This is why linoleic acid
and not conjugated linoleic acid was tested on these beads. However, Satory and Smith
reported that conjugated linoleic acid inhibits preadipocyte proliferation and promotes
lipid filling of these cells over a range of concentrations [30]. Also, since conjugated
linoleic acid is composed of positional and geometric isomers of linoleic acid, the type of
linoleic acid may have different effects on preadipocytes [41, 42]. The reason we did not
see any significant differences between the beads coated with collagen and the beads
coated with collagen and linoleic acid is likely due to the concentration of linoleic acid on
the surface of the beads. One linoleic acid concentration was chosen in order to simply
determine if linoleic acid could be added to the surface of the beads.
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The DSC results indicate that the original polymer used to construct the PL
scaffolds is semi-crystalline. There were no DSC-induced crystallization peaks but a
melting peak was present. The polylactide microsphere fabrication process did not affect
the crystallinity of the polymer.
The fabrication of the PL beads did decrease the molecular weight of the polymer.
The creation of the PL beads likely cleaves the larger molecular weight chains, causing a
decrease in overall weight average molecular weight. The polydispersity of a polymer is
the ratio of weight average molecular weight to the number average molecular weight,
and is an indication of the distribution of molecular weights within the polymer. There
was no significant difference between the as-received PL and the PL beads indicating that
fabrication of the beads did not affect distribution of the molecular weights.
The scaffolds selected were tested with the goal of eventual use in an injectable
composite system. The composite system may include different types of beads that will
serve specific purposes. Collagen and linoleic acid coated beads could serve as cell
attachment sites, while PL beads could serve another purpose other than cellular
interaction. The fabrication and degradation of PL., as well as the cellular and tissue
reaction to PL have been well documented by many researchers [18, 43]. PL could serve
many functions in a composite system, such as a bulking agent, a mechanical support
device, or a delivery system for growth factors, differentiation components, or therapeutic
drugs.

70

CONCLUSIONS
In the initial study, collagen was encapsulated in polylactide beads, which caused
the beads to be 13 times smaller than polylactide beads. These beads were cultured with
fibroblasts in stir flasks and tested for cellular viability. Cells cultured with the collagen
encapsulated beads attached to the beads and proliferated on them through out the entire
culture period, while cells cultured with the polylactide beads did not attach to the beads
but aggregated together instead. Collagen was not proven to be present in the beads and
therefore were not tested further.
Two types of coated polylactide beads were created and tested in a cell culture of
preadipocytes. Coating the polylactide affected cellular attachment, cellular proliferation,
and triglyceride and fatty acid production.

The collagen coating increased cellular

attachment, proliferation, and triglyceride production of the preadipocytes compared to
that resulting from culture with uncoated polylactide beads. The concentration of linoleic
acid in the coating did not have a measurable affect on cellular activity, but linoleic acid
added to medium on a 2-D plate increased fatty acid production in preadipocytes.
Collagen coated beads show promise to be used in a tunable system as cellular carriers
and for the promotion of cellular growth. Coated and uncoated scaffolds can be used in
combination to form an injectable composite system, the coated beads functioning as a
cellular carrier and the uncoated beads serving as a drug delivery or tissue bulking
device.
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RECOMMENDATIONS
Future studies should research an optimal concentration of linoleic acid for
inducing differentiation in preadipocytes.
Studies should research coating different concentrations of linoleic acid on the
surface of microspheres.
Further studies should research the effects of differing concentrations of tannic
acid on collagen and linoleic acid content in the surface coating.
Other types of fatty acid should be researched as a coating for microspheres.
Real time RT-PCR and more preadipocyte and adipocyte specific genes should be
used to evaluate the gene expression.
More research should go into optimizing the gas chromatography procedure for
polymer beads.
A co-culture of preadipocytes with other cells found in the breast should be
researched further.
Further studies should determine an appropriate hydrogel carrier for the injectable
beads.
Future studies should be designed to test the effects of shear forces from injection
on the integrity of the collagen coating.
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APPENDICES

APPENDIX A

Figure A-1: 12-well plate layout for assessment of cellular activity and differentiation on
2-D versus 3-D scaffolds
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